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Background
Aside from caffeine, there is a relative dearth of evidence
regarding natural ingredients that enhance subjective
“energy” levels. We have studied a unique, naturally occur-
ring purine alkaloid, present in Camellia assamica variety
kucha tea (amongst other botanical sources) that acts on
both adenosinergic and dopaminergic pathways that
appears to influence multiple neurochemical pathways. As
a first step in a series of experiments, we examined the
effects of TeaCrine™, a nature-identical, chemically
equivalent bioactive compound known as theacrine
(1,3,7,9-tetramethyluric acid), in humans.
Methods
Using a randomized, double-blinded, within-subject
(crossover) design, 15 healthy subjects (mean ± SD age,
height, wgt, BMI: 28.3 ± 6.1 y, 175.7 ± 11.5 cm, 89.8 ±
21.7 kg, 29.1 ± 4.7) volunteered to ingest 200 mg of
TeaCrine™ (Compound Solutions, Inc., Carlsbad, CA)
(TC) or Placebo (PLA). Anchored VAS questionnaires
were used to detect changes in various aspects of physi-
cal and mental energy and performance; side effect pro-
files, hemodynamics and biochemical markers of safety
were also collected over a 3-hr post-dosing period.
A subset of 6 subjects underwent a separate 7-day,
open-label, repeated dose study comparing 100 mg,
200 mg and 400 mg of TC. Consent to publish the
results was obtained from all participants.
Results
The 200 mg dose of TC caused significant improve-
ments in energy (TC: +8.6% vs. PLA: -5.7%, P=0.049)
and reductions in fatigue (TC: -6.7% vs. PLA: +5.8%,
P=0.04). A trend for improved concentration was also
noted (TC: +2.4% vs. PLA: -1.3%, P=0.07). No changes in
systemic hemodynamics or side effect profiles were noted.
The N=6 cohort study demonstrated moderate to large
effect sizes (0.50 to 0.71) with the 200 mg dose of TC over
a 7-day period of assessment for the following subjective
measures: energy, fatigue, concentration, anxiety, motiva-
tion to exercise and libido.
Conclusion
These preliminary data support the benefits of acute
TeaCrine™ supplementation on subjective “energy”
levels and some indices of mental performance. Future
studies are underway to confirm these neurotropic
effects and also explore potential benefits of TeaCrine™
on objective measures of cognitive and physical perfor-
mance, inflammation, pain perception, and functional
capacity.
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